"Regardless of the insurance and of their access to prescription treatment, there are considerable risks associated with being a member of a racial and ethnic community, and increased risk of ...

Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence. Lars H.

Nearly 90% of adults had maintenance OCS dose of 5mg/day or less after 52 weeks of treatment. HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, ...

Use of digital measurement tools to track individual adherence to treatment helped avoid raising doses or adding medications and improved adherence in patients with uncontrolled asthma, the INCA Sun ...

In the pooled analysis of KALOS and LOGOS, BREZTRI also demonstrated clinically meaningful reductions in the annualized rate of severe asthma exacerbations versus ICS/LABA medicines in patients with ...

Please provide your email address to receive an email when new articles are posted on . Less than 15% of PCPs reported managing patients with uncontrolled asthma at least once a week. More PCPs ...

Asthma diagram, lungs A post hoc analysis of the QUEST trial assessed clinical remission in patients with moderate-to-severe asthma after 24 and 52 weeks of dupilumab treatment. The following article ...

Lemanske RF, Mauger DT, Sorkness CA, et al, for the Childhood Asthma Research and Education (CARE) Network of the National, Heart, Lung, and Blood Institute. This study evaluated whether any of 3 ...

Please provide your email address to receive an email when new articles are posted on . Data were derived from Silberman J, et al. JAMA Netw Open. 2025;doi:10.1001 ...

In a recent study published in the Respiratory Research journal, researchers in Hong Kong assessed the deterioration of asthma control in patients recovering from mild to moderate coronavirus disease ...